Skip to content

Effects of Neuromuscular Electrical Stimulation and Pollock Protein on Lower Limb Muscle Strength in Elderly Hospitalized Patients

Effects of Neuromuscular Electrical Stimulation and Pollock Protein on Lower Limb Muscle Strength in Elderly Hospitalized Patients - Effects of Neuromuscular Electrical Stimulation and Pollock Protein on Lower Limb Muscle Strength in Elderly Hospitalized Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061888
Enrollment
50
Registered
2026-06-12
Start date
2024-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients admitted to the Community Comprehensive Care Unit

Interventions

Conventional rehabilitation for 6 weeks Neuromuscular electrical stimulation (30 min/day, 5 times/week) in addition to conventional rehabilitation for 6 weeks Neuromuscular electrical stimulation (30

Sponsors

Kansai Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Participants who are eligible for oral intake of food (regardless of whether or not they are able to eat independently) 2) Participants who have been fully informed about their participation in this study, and who have given written consent of their own free will based on their full understanding of the study

Exclusion criteria

Exclusion criteria: The participants who fall into any of the following criteria will not be included in this study. 1) Participants with food allergies to dairy products, fish, eggs, wheat, soybeans, etc. 2) Participants with restricted protein intake 3) Participants who have an electronic device inserted in the body, such as a pacemaker, that can be affected by electrical stimulation of NMES 4) Participants with severe sensory impairment 5) Participants with progressive neuromuscular diseases 6) Participants with malignant tumors 7) Participants with a history of peripheral nerve disease of the lower limb 8) Participants with a history of cerebrovascular disease (Brunnstrome stage < V of the lower limb ) 9) Participants who have been instructed by a physician to limit their activities, such as not-bearing or bed rest 10) Participants who are judged by the research director to be inappropriate to participate in the study for reasons other than those listed above

Design outcomes

Primary

MeasureTime frame
Knee extensor muscle strength before and after 6 weeks

Secondary

MeasureTime frame
Grip strength, muscle thickness (thigh), body composition, physical function (10m walking speed, Short Physical Performance Battery), ADL (FIM), frailty (Kihon checklist), nutrition (Mini-Nutritional Assessment), and oral and swallowing function (tongue pressure, Oral Health Assessment) before and after 6 weeks

Countries

Japan

Contacts

Public ContactToshiaki Miyamoto

Kansai Medical University Faculty of Rehabilitation

miyamott@makino.kmu.ac.jp072-856-2361

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026